Prescription and use of antidepressants in adolescents: a systematic review

Detalhes bibliográficos
Autor(a) principal: Souza, Amanda Lacerda de
Data de Publicação: 2021
Outros Autores: Silva, Wagner Resende, Piva, Leticia
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Scire Salutis
DOI: 10.6008/CBPC2236-9600.2022.001.0028
Texto Completo: https://sustenere.inf.br/index.php/sciresalutis/article/view/6458
Resumo: In the last two decades, the occurrence of depression has shown an increasing inclination among the adolescent population, drawing attention due to the fact that the characteristics of the disease manifest more severely in this population, resulting in a negative impact of the disease on their social, family, and school relationships. The most widespread treatment for depression among psychiatrists is the use of psychotropic drugs, which generally inhibit the reuptake of neurotransmitters or decrease their destruction, resulting in an increase of neurotransmitters in the synaptic cleft. However, when it comes to adolescents, the choice of psychotropic drugs should pay attention to the lower risk of causing side effects, as well as initiating treatment with low therapeutic doses, considering the individuality and fragility of each organism. In this sense, this article has the general objective of performing a systematic review of the literature on the use and prescription of antidepressants in adolescents from 10 to 19 years of age. The scientific articles were selected from the electronic databases PubMed, LILACS, and SciELO, with a time frame of 2011 to 2021, and in Portuguese. A detailed analysis of the scientific articles was performed, resulting in 6 articles for analysis.  According to the results obtained, it was concluded that the Selective Serotonin Reuptake Inhibitors is the class of antidepressants most commonly used in adolescents, especially because it is the latest generation, has fewer side effects, and has good adherence to treatment.
id ESS-1_7dbec31b7c60474e6fa70431f111b4ed
oai_identifier_str oai:ojs.pkp.sfu.ca:article/6458
network_acronym_str ESS-1
network_name_str Scire Salutis
spelling Prescription and use of antidepressants in adolescents: a systematic reviewPrescrição e uso de antidepressivos em adolescentes: uma revisão sistemáticaDepressãoAdolescênciaAntidepressivosDepressionAdolescenceAntidepressantsIn the last two decades, the occurrence of depression has shown an increasing inclination among the adolescent population, drawing attention due to the fact that the characteristics of the disease manifest more severely in this population, resulting in a negative impact of the disease on their social, family, and school relationships. The most widespread treatment for depression among psychiatrists is the use of psychotropic drugs, which generally inhibit the reuptake of neurotransmitters or decrease their destruction, resulting in an increase of neurotransmitters in the synaptic cleft. However, when it comes to adolescents, the choice of psychotropic drugs should pay attention to the lower risk of causing side effects, as well as initiating treatment with low therapeutic doses, considering the individuality and fragility of each organism. In this sense, this article has the general objective of performing a systematic review of the literature on the use and prescription of antidepressants in adolescents from 10 to 19 years of age. The scientific articles were selected from the electronic databases PubMed, LILACS, and SciELO, with a time frame of 2011 to 2021, and in Portuguese. A detailed analysis of the scientific articles was performed, resulting in 6 articles for analysis.  According to the results obtained, it was concluded that the Selective Serotonin Reuptake Inhibitors is the class of antidepressants most commonly used in adolescents, especially because it is the latest generation, has fewer side effects, and has good adherence to treatment.Nas últimas duas décadas, a ocorrência de depressão tem apresentado inclinação crescente entre a população de adolescentes, chamando atenção devido às características da doença se manifestarem de forma mais grave nessa população, decorrendo impacto negativo da doença na sua relação social, familiar e escolar. O tratamento da depressão mais propagado entre psiquiatras decorre do uso de psicofármacos, que de modo geral inibem a recaptação dos neurotransmissores ou diminuem a sua destruição, sucedendo num aumento dos neurotransmissores na fenda sináptica. Conquanto, em se tratando de adolescentes a escolha de psicofármacos deve atentar o menor risco de causar efeitos colaterais, assim como iniciar o tratamento com doses terapêuticas baixas, ao considerar a individualidade e fragilidade de cada organismo. Nesse sentido, este artigo tem como objetivo geral realizar uma revisão sistemática da literatura sobre o uso e prescrição de antidepressivos em adolescentes de 10 a 19 anos de idade. Os artigos científicos foram selecionados nas bases de dados eletrônicos do PubMed, LILACS e SciELO, com recorte temporal de 2011 a 2021, e idioma na língua portuguesa. Foi realizada análise detalhada dos artigos científicos, resultando 6 para análise.  De acordo com os resultados obtidos, conclui-se que os Inibidores Seletivos de Recaptação de Serotonina é a classe de antidepressivos de maior uso em adolescentes, sobretudo em virtude de ser de última geração, apresentar menos efeitos colaterais e ter boa adesão ao tratamento.Sustenere Publishing2021-10-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://sustenere.inf.br/index.php/sciresalutis/article/view/645810.6008/CBPC2236-9600.2022.001.0028Scire Salutis; Vol. 12 No. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 253-261Scire Salutis; Vol. 12 Núm. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 253-261Scire Salutis; v. 12 n. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 253-2612236-9600reponame:Scire Salutisinstname:Companhia Brasileira de Produção Científica (CBPC)instacron:ESSporenghttps://sustenere.inf.br/index.php/sciresalutis/article/view/6458/3507https://sustenere.inf.br/index.php/sciresalutis/article/view/6458/3506Copyright (c) 2021 Scire Salutishttp://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessSouza, Amanda Lacerda deSilva, Wagner ResendePiva, Leticia2023-01-04T20:16:22Zoai:ojs.pkp.sfu.ca:article/6458Revistahttps://sustenere.co/index.php/sciresalutisONGhttps://sustenere.co/index.php/sciresalutis/oai||carlos@arvore.org.br2236-96002236-9600opendoar:2023-01-04T20:16:22Scire Salutis - Companhia Brasileira de Produção Científica (CBPC)false
dc.title.none.fl_str_mv Prescription and use of antidepressants in adolescents: a systematic review
Prescrição e uso de antidepressivos em adolescentes: uma revisão sistemática
title Prescription and use of antidepressants in adolescents: a systematic review
spellingShingle Prescription and use of antidepressants in adolescents: a systematic review
Prescription and use of antidepressants in adolescents: a systematic review
Souza, Amanda Lacerda de
Depressão
Adolescência
Antidepressivos
Depression
Adolescence
Antidepressants
Souza, Amanda Lacerda de
Depressão
Adolescência
Antidepressivos
Depression
Adolescence
Antidepressants
title_short Prescription and use of antidepressants in adolescents: a systematic review
title_full Prescription and use of antidepressants in adolescents: a systematic review
title_fullStr Prescription and use of antidepressants in adolescents: a systematic review
Prescription and use of antidepressants in adolescents: a systematic review
title_full_unstemmed Prescription and use of antidepressants in adolescents: a systematic review
Prescription and use of antidepressants in adolescents: a systematic review
title_sort Prescription and use of antidepressants in adolescents: a systematic review
author Souza, Amanda Lacerda de
author_facet Souza, Amanda Lacerda de
Souza, Amanda Lacerda de
Silva, Wagner Resende
Piva, Leticia
Silva, Wagner Resende
Piva, Leticia
author_role author
author2 Silva, Wagner Resende
Piva, Leticia
author2_role author
author
dc.contributor.author.fl_str_mv Souza, Amanda Lacerda de
Silva, Wagner Resende
Piva, Leticia
dc.subject.por.fl_str_mv Depressão
Adolescência
Antidepressivos
Depression
Adolescence
Antidepressants
topic Depressão
Adolescência
Antidepressivos
Depression
Adolescence
Antidepressants
description In the last two decades, the occurrence of depression has shown an increasing inclination among the adolescent population, drawing attention due to the fact that the characteristics of the disease manifest more severely in this population, resulting in a negative impact of the disease on their social, family, and school relationships. The most widespread treatment for depression among psychiatrists is the use of psychotropic drugs, which generally inhibit the reuptake of neurotransmitters or decrease their destruction, resulting in an increase of neurotransmitters in the synaptic cleft. However, when it comes to adolescents, the choice of psychotropic drugs should pay attention to the lower risk of causing side effects, as well as initiating treatment with low therapeutic doses, considering the individuality and fragility of each organism. In this sense, this article has the general objective of performing a systematic review of the literature on the use and prescription of antidepressants in adolescents from 10 to 19 years of age. The scientific articles were selected from the electronic databases PubMed, LILACS, and SciELO, with a time frame of 2011 to 2021, and in Portuguese. A detailed analysis of the scientific articles was performed, resulting in 6 articles for analysis.  According to the results obtained, it was concluded that the Selective Serotonin Reuptake Inhibitors is the class of antidepressants most commonly used in adolescents, especially because it is the latest generation, has fewer side effects, and has good adherence to treatment.
publishDate 2021
dc.date.none.fl_str_mv 2021-10-22
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://sustenere.inf.br/index.php/sciresalutis/article/view/6458
10.6008/CBPC2236-9600.2022.001.0028
url https://sustenere.inf.br/index.php/sciresalutis/article/view/6458
identifier_str_mv 10.6008/CBPC2236-9600.2022.001.0028
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://sustenere.inf.br/index.php/sciresalutis/article/view/6458/3507
https://sustenere.inf.br/index.php/sciresalutis/article/view/6458/3506
dc.rights.driver.fl_str_mv Copyright (c) 2021 Scire Salutis
http://creativecommons.org/licenses/by-nc-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Scire Salutis
http://creativecommons.org/licenses/by-nc-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sustenere Publishing
publisher.none.fl_str_mv Sustenere Publishing
dc.source.none.fl_str_mv Scire Salutis; Vol. 12 No. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 253-261
Scire Salutis; Vol. 12 Núm. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 253-261
Scire Salutis; v. 12 n. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 253-261
2236-9600
reponame:Scire Salutis
instname:Companhia Brasileira de Produção Científica (CBPC)
instacron:ESS
instname_str Companhia Brasileira de Produção Científica (CBPC)
instacron_str ESS
institution ESS
reponame_str Scire Salutis
collection Scire Salutis
repository.name.fl_str_mv Scire Salutis - Companhia Brasileira de Produção Científica (CBPC)
repository.mail.fl_str_mv ||carlos@arvore.org.br
_version_ 1822179460433051648
dc.identifier.doi.none.fl_str_mv 10.6008/CBPC2236-9600.2022.001.0028